Few therapeutic options are available for patients with Neurofibromatosis Type II. Here, the authors identify G6PD as a potential pharmacological target and show that NF2 mutant Schwann cells are in an oxidized state and die when G6PD is inhibited.
- Athena Kyrkou
- Robert Valla
- Aurelio A. Teleman